Walgreens Boots Alliance, Inc. - Common Stock (WBA)
11.18
+0.02 (0.18%)
NASDAQ · Last Trade: Apr 2nd, 8:33 PM EDT
Detailed Quote
Previous Close
11.16
Open
11.13
Bid
11.09
Ask
11.14
Day's Range
11.11 - 11.22
52 Week Range
8.080 - 21.74
Volume
9,254,534
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
1.000 (8.94%)
1 Month Average Volume
21,709,260
About Walgreens Boots Alliance, Inc. - Common Stock (WBA)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets. The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products. Read More
The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant ALDI located at 2629 Crawfordville Hwy in Crawfordville, FL for $4,100,000.
$AMOD Reports Major Deployment of High Tech Financial Kiosks Targeting $75 Million Annual Revenue, Plus Ongoing Patent Infringement Actions vs. Walgreens and Other Top RetailersCORNELIUS, N.C. - March 17, 2025 - PRLog -- Marketing Technology Company with a Core Focus on Artificial Intelligence (AI) in The Broad Retail Business Sector.Strong Fundamentals, Ongoing Growth Strategy and Commitment to Delivering Value to AMOD shareholdersLarge-Scale Deployment of AI Powered Financial Kiosks Across Vast Network of Supermarkets Targeting $75 Million in Annual Ad Revenue.New Agreement with GlobeTopper to Boost Revenue Growth in Prepaid and Digital Transactions.High Value Legal Settlement with Shelf Nine and Strategic Partnership Plans Including Perpetual License for AMOD Patented Innovations.Ongoing Patent Infringement Actions vs. Walgreens and Other Top Retailers.Retail Expansion Targeting $75 Million in Annual Ad Revenue.Alpha Modus Corp. (Stock Symbol: AMOD) is a technology company with a core focus on artificial intelligence (AI) in retail business. Alpha Modus covers a variety of inventory management and advertising features, including the presentation and display of relevant and targeted advertising that is based on customer shopping habits, foot traffic, or other criteria. The Company engages in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.Landmark Settlement with Open Door for a Game-Changing PartnershipOn March 17th AMOD announced a groundbreaking settlement in its patent infringement lawsuit against Wakefern and Shelf Nine. As part of this resolution, AMOD and Shelf Nine have reached a settlement agreement, while Shelf Nine's parent company, VSBLTY Groupe Technologies Corp. will negotiate a strategic partnership for the deployment of AMOD cutting-edge technology which would include a perpetual license for AMOD patented innovations.The lawsuit—one of several filed by AMOD against major retailers and digital signage networks, including Walgreens, Kroger, Wakefern, Shelf Nine, and Brookshire Grocery—centered on proprietary technology designed to enhance digital engagement and data-driven retail solutions. This agreement not only validates AMOD intellectual property rights but also establishes a long-term opportunity to integrate AMOD technology with VSBLTY's proprietary and robust data analytics software once VSBLTY Groupe Technologies and AMOD finalize their strategic partnership agreement.Through the proposed partnership agreement, Shelf Nine's parent company VSBLTY Groupe Technologies will leverage AMOD proprietary solutions to enhance its retail media network, providing advertisers and retailers with state-of-the-art tools to optimize in-store customer engagement. This settlement and future strategic alliance reinforce both companies' market position while opening new avenues for growth and technology deployment.Furthermore, AMOD believes that numerous companies are currently infringing on its patent portfolio. This settlement strengthens the company's ability to pursue further enforcement actions and ensures that its innovative technologies are recognized and respected throughout the industry. AMOD remains steadfast in protecting its intellectual property and will take decisive action, if necessary, to uphold its rights.AMOD believes the investment community will closely monitor the implications of this agreement, as it not only fortifies the AMOD intellectual property portfolio but also demonstrates its ability to drive sustained value through both innovation and strategic partnerships—while underscoring its commitment to enforcing its IP rights when required.AI-Powered Retail Expansion Targeting $75 Million in Annual Ad RevenueOn February 13th AMOD forecasted substantial growth as its partner, CashX, and began the large-scale deployment of its financial kiosks across a vast network of supermarkets beginning in California and Colorado. With a contracted deployment expected in approximately 10,000 locations, this initiative represents a transformational moment for AMOD and its investors."We see our AI technology revolutionizing the self-service financial kiosk industry, creating an entirely new revenue stream while providing critical services to millions of consumers," said AMOD CEO William Alessi. "With projected advertising revenue alone reaching $75 million annually, we plan on delivering scalable, high-margin revenue growth for our investors during the deployment period. This deployment is intended to solidify our market leadership and position Alpha Modus as the backbone of AI-driven financial automation in retail."Each AMOD AI-powered CashX kiosk is expected to serve 1,250 unique visitors per month, reaching 150 million unique visits per year in the aggregate once all of the kiosks are fully deployed. This high engagement is projected to generate $75 million in annual ad revenue for Alpha Modus, significantly boosting Alpha Modus's financial outlook.Strategic Reseller Agreement with GlobeTopper (Stock Symbol: ASII), Expanding Revenue Opportunities in Prepaid and Digital TransactionsOn February 10th AMOD announced a strategic reseller agreement with GlobeTopper (Stock Symbol: ASII), a premier platform for prepaid products and digital transaction solutions. This partnership should strengthen both the AMOD and ASII market positions and create new revenue streams through an innovative revenue-sharing model. For more information on ASII GlobeTopper visit www.globetopper.com/. Under this agreement, AMOD gains the exclusive right to resell GlobeTopper's suite of digital transaction solutions—including prepaid cards, event tickets, cryptocurrency services, and remittance products—to a targeted network of retailers where CashX AI-powered kiosks are deployed. The integration of ASII CashX AI into AMOD technology ecosystem enhances the accessibility and automation of digital financial transactions, further differentiating the Company in the evolving retail technology landscape.For more information on $AMOD visit: alphamodus.comMedia Contact:Company Names: Alpha Modus Corp. (Stock Symbol: AMOD)Contact: Investor RelationsEmail: ir@alphamodus.comPhone: (704) 252-5050Country: United StatesWebsite: alphamodus.comDISCLAIMER: https://corporateads.com/disclaimer/Disclosure listed on the CorporateAds website
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”) (NASDAQ: WBA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 25-cv-01058, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Walgreens common stock between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Walgreens has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 22.7% and now trades at $11.12. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 25-cv-01058, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Walgreens common stock between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025. Walgreens describes itself as a “healthcare, pharmacy, and retail company.”
Shares of data-mining and analytics company Palantir (NYSE:PLTR)
fell 6.1% in the morning session after Jefferies analysts reiterated a Sell rating, raising concerns about the stock's valuation. The analysts added, "This positive momentum is baked into PLTR's valuation at 45x CY26E, the most expensive stock in our coverage. Fundamentals have been strong, but valuation remains the biggest concern, and insiders continue to sell, with co-founder Stephen Cohen selling another $310M in shares over the past few days."
Stefano Pessina will nearly double his Walgreens stake to 30% in Sycamore's $23.7 billion buyout, positioning himself for a key role as the company faces potential restructuring.
Alpha Modus Corp. (Nasdaq: AMOD ) is a technology company with a core focus on artificial intelligence (AI) in retail business. Alpha Moduscovers a variety of inventory management and advertising features, including the presentation and display of relevant and targeted advertising that is based on customer shopping habits, foot traffic, or other criteria. The Company engages in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
BALA CYNWYD, Pa., March 17, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
NEW YORK - March 17, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) on behalf of investors that purchased or otherwise acquired Walgreens securities between April 2, 2020 and January 16, 2025 (the “Class Period”).
